Ampio pharmaceuticals, inc. reports first quarter 2021 financial results and provides business update

Englewood, colo., may 5, 2021 /prnewswire/ --  ampio pharmaceuticals (nyse american: ampe), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory conditions for which there are limited treatment options, today reported quarterly financial results for the first quarter period ended march 31, 2021, and provided a corporate overview and business update.
AMPE Ratings Summary
AMPE Quant Ranking